Fmoc-D-Cpa-OH is a protected amino acid derivative featuring a D-configured amino acid core bearing the Cpa side chain, with the α-amino group and carboxyl functionality incorporated into a protected, peptide-synthesis-ready structure. The molecule contains an Fmoc (9H-fluoren-9-ylmethoxycarbonyl) protecting group on the amino moiety, while the carboxyl group is present as a free acid (-CO2H), and the side chain provides the characteristic functionality of Cpa for incorporation into designed peptide frameworks. In synthetic peptide chemistry, Fmoc-protected amino acids like this one are used as building blocks for stepwise assembly and for preparing peptide analogues used in structure-activity studies, chemical biology labeling strategies, and analytical characterization of peptide products.
CAT No: CP25452
CAS No:170642-29-2
Synonyms/Alias:170642-29-2;Fmoc-D-Cyclopropylalanine;Fmoc-beta-cyclopropyl-D-Ala-OH;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclopropylpropanoicacid;Fmoc-L-Cyclopropylalanine;AmbotzFAA1763;AC1MBT0O;Fmoc-b-cyclopropyl-D-Ala-OH;CTK8B8702;MolPort-003-725-632;ZINC2392277;ANW-61079;CF-731;AJ-35825;AK-63308;KB-209628;RT-012915;TL8006288;Z5683;(2R)-3-cyclopropyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoicacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-cyclopropyl-D-alanine
Fmoc-D-Cpa-OH is an Fmoc-protected D-configured amino acid derivative designed for peptide chemistry and chiral intermediate synthesis. The molecule contains an Fmoc carbamate on the amino functionality, a free carboxylic acid for C-terminal activation, and a stereogenic center characteristic of the D-amino acid framework, which enables stereochemically defined peptide incorporation. The side-chain substitution pattern of D-Cpa (cyclopropyl-containing amino acid motif) provides a compact, conformationally constrained hydrophobic element that can influence local backbone geometry and binding-site interactions in peptide and peptidomimetic scaffolds. The combination of an orthogonally removable Fmoc group and a reactive carboxyl group supports standard peptide coupling strategies and downstream derivatization into protected or activated amino acid building blocks.
1. Peptide Synthesis
Fmoc-D-Cpa-OH is suitable for solid-phase peptide synthesis and automated peptide assembly where Fmoc protection enables controlled N-deprotection and subsequent coupling cycles. The Fmoc carbamate masks the amino group while the free carboxylic acid participates in peptide bond formation after activation, supporting incorporation as a defined D-residue at internal or terminal positions. The D stereochemistry and cyclopropyl-containing side chain can be used to modulate conformational preferences, improve resistance to proteolysis in peptide analogs, and tune side-chain packing in structure-activity relationship studies. The resulting D-Cpa-containing peptides can serve as research-grade materials for binding studies, synthetic standards, and peptidomimetic construction.
2. Peptidomimetics And SAR Studies
Fmoc-D-Cpa-OH is employed in medicinal chemistry research for designing peptidomimetics that retain key spatial features of bioactive peptides while introducing stereochemical and steric constraints. The D configuration and compact cyclopropyl-like side-chain functionality can be leveraged to probe how rigid hydrophobic substituents affect receptor or enzyme recognition in SAR workflows. Fmoc-based peptide building block handling supports rapid generation of analog libraries where the D-Cpa residue can be introduced at specific sequence contexts for comparative studies. The ability to vary coupling position and neighboring residues enables systematic mapping of structure-function relationships for amino acid-derived pharmacophores and constrained scaffold development.
3. Chiral Building Block Development
Fmoc-D-Cpa-OH functions as a chiral amino acid intermediate for stereochemically controlled synthesis of D-configured derivatives used in asymmetric route design. The presence of the Fmoc-protected amine and free carboxylic acid allows conversion into activated esters, amides, or peptide coupling reagents while preserving the D stereocenter. The cyclopropyl-containing side-chain motif can serve as a stereochemical "handle" for constructing hydrophobic fragments in chiral synthesis, including side-chain functionalization strategies that retain configurational integrity. Downstream use may include preparation of D-Cpa analogs, N-protected variants, and activated intermediates for fine chemical synthesis and process chemistry development.
4. Side-Chain Functionalization
Fmoc-D-Cpa-OH supports amino acid derivatization workflows where the carboxylic acid and protected amine enable orthogonal transformations. The Fmoc group provides a stable nitrogen protection strategy during side-chain modifications, while the carboxyl functionality can be converted to amide, ester, or activated intermediates for attaching linkers, handles, or solubilizing groups. The constrained hydrophobic side chain can be retained while introducing additional functionality through subsequent synthetic steps, enabling generation of functionalized D-amino acid derivatives for conjugation chemistry and molecular scaffold tuning. The resulting products can be used as intermediates for building larger constructs such as constrained peptide analogs, labeled probes, or library members requiring defined stereochemistry.
5. Chemical Manufacturing Intermediates
Fmoc-D-Cpa-OH can be applied in specialty chemical production as a standardized, Fmoc-protected amino acid input for manufacturing workflows that require reproducible chiral building blocks. The Fmoc protection strategy aligns with common peptide-manufacturing logistics, where N-protection and deprotection steps are integrated into sequential coupling operations to build defined sequences. The free carboxylic acid enables conversion to activated forms suitable for controlled downstream assembly into peptide intermediates, peptidomimetic fragments, or further protected derivatives. Process chemistry relevance arises from the stable handling of an Fmoc-protected D-amino acid intermediate that can be scaled for consistent incorporation into peptide building block preparations and industrial fine chemical synthesis.
6. Analytical Research Standards
Fmoc-D-Cpa-OH is suitable for analytical research where defined stereochemistry and a protected amino acid backbone support method development and reference material preparation. The Fmoc group and the free carboxylic acid allow detection and characterization workflows that distinguish protected amino acid forms from deprotected or derivatized analogs using chromatographic and spectrometric methods. The D configuration and cyclopropyl-containing side chain provide a stereochemically specific signature that can be used to validate peptide coupling outcomes, monitor impurity profiles, or support calibration of analytical assays for peptide building block integrity. Downstream, D-Cpa-containing peptides or derivatives generated from this building block can serve as structural references in peptide chemistry research and quality-oriented characterization of amino acid-derived intermediates.
1. Myotropic activity of allatostatins in tenebrionid beetles
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Cationic cell-penetrating peptides are potent furin inhibitors
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.